EQUINE THYMOCYTE IMMUNE GLOBULIN

EQUINE THYMOCYTE IMMUNE GLOBULIN was reported 1032 times

EQUINE THYMOCYTE IMMUNE GLOBULIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ENDOMETRIAL SARCOMA METASTATIC 1 0.2500
1 STAPHYLOCOCCAL MEDIASTINITIS 4 0.1818
2 ENCEPHALITIS POST MEASLES 1 0.1667
3 DIFFUSE CUTANEOUS MASTOCYTOSIS 5 0.1667
4 MYOCARDITIS TOXOPLASMAL 2 0.1176
5 SEROCONVERSION TEST POSITIVE 6 0.1132
6 LICHEN STRIATUS 1 0.0667
7 EVAN'S SYNDROME 1 0.0588
8 CONGENITAL DYSKERATOSIS 1 0.0526
9 GRAM STAIN NEGATIVE 1 0.0526
10 CENTRAL HYPOTHYROIDISM 13 0.0393
11 CD8 LYMPHOCYTES INCREASED 2 0.0323
12 NON-HODGKIN'S LYMPHOMA STAGE IV 1 0.0323
13 NECROTISING GASTRITIS 1 0.0312
14 MYOCARDITIS BACTERIAL 1 0.0303
15 CLONAL EVOLUTION 3 0.0288
16 GINGIVECTOMY 1 0.0286
17 HEMISENSORY NEGLECT 1 0.0286
18 HEPATIC NEOPLASM MALIGNANT RECURRENT 3 0.0283
19 CSF LYMPHOCYTE COUNT ABNORMAL 1 0.0278
20 EPSTEIN-BARR VIRUS ANTIGEN POSITIVE 3 0.0259
21 NEONATAL MULTI-ORGAN FAILURE 1 0.0200
22 PRIMARY HYPOGONADISM 3 0.0191
23 VIRAL HAEMORRHAGIC CYSTITIS 13 0.0183
24 COMPLICATIONS OF BONE MARROW TRANSPLANT 6 0.0166
25 HAEMORRHAGIC PNEUMONIA 1 0.0161
26 GLOMERULONEPHRITIS FOCAL 1 0.0159
27 CARDIAC PSEUDOANEURYSM 1 0.0145
28 COLD AGGLUTININS POSITIVE 1 0.0143
29 POLYOMAVIRUS VIRAEMIA 15 0.0141
30 BACTERIAL CULTURE POSITIVE 1 0.0141
31 HEPATOSPLENIC CANDIDIASIS 2 0.0136
32 CYTOMEGALOVIRUS OESOPHAGITIS 5 0.0136
33 ANTI-THYROID ANTIBODY 1 0.0133
34 ALLERGIC TRANSFUSION REACTION 2 0.0132
35 FUNGAL ABSCESS CENTRAL NERVOUS SYSTEM 1 0.0132
36 BLOOD BRAIN BARRIER DEFECT 2 0.0132
37 TRANSPLANT DYSFUNCTION 23 0.0129
38 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 6 0.0128
39 SERUM SICKNESS 35 0.0125
40 ABDOMINAL WALL ANOMALY 1 0.0112
41 HAEMOSIDEROSIS 3 0.0112
42 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 4 0.0110
43 CYTOMEGALOVIRUS ANTIGEN POSITIVE 2 0.0109
44 MEGAKARYOCYTES DECREASED 1 0.0108
45 AEROMONAS INFECTION 2 0.0106
46 ENGRAFT FAILURE 3 0.0105
47 HEPATITIS INFECTIOUS MONONUCLEOSIS 1 0.0103
48 MASTOID DISORDER 1 0.0101
49 JEJUNAL ULCER 2 0.0099
50 RETICULOCYTE COUNT INCREASED 8 0.0099
51 POST TRANSPLANT DISTAL LIMB SYNDROME 2 0.0099
52 PNEUMOCYSTIS CARINII PNEUMONIA 2 0.0099
53 SODIUM RETENTION 2 0.0098
54 APOPTOSIS 3 0.0097
55 PERICARDITIS CONSTRICTIVE 4 0.0095
56 FOCAL GLOMERULOSCLEROSIS 1 0.0094
57 MUCOCUTANEOUS ULCERATION 2 0.0088
58 LUMBAR PUNCTURE ABNORMAL 1 0.0086
59 CD4 LYMPHOCYTES INCREASED 2 0.0086
60 GRAFT VERSUS HOST DISEASE IN LIVER 6 0.0084
61 DISSEMINATED TOXOPLASMOSIS 1 0.0083
62 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 2 0.0082
63 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 7 0.0076
64 OSTEOMYELITIS BACTERIAL 2 0.0073
65 DUODENITIS HAEMORRHAGIC 1 0.0072
66 CRANIAL NERVE PALSIES MULTIPLE 1 0.0071
67 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 5 0.0070
68 ENDOMETRIAL ATROPHY 1 0.0069
69 RENAL TUBULAR ATROPHY 6 0.0068
70 ENGRAFTMENT SYNDROME 4 0.0068
71 ERYTHROSIS 1 0.0066
72 MYCOPLASMA TEST POSITIVE 1 0.0066
73 ENTEROCOLITIS VIRAL 2 0.0066
74 DONOR SPECIFIC ANTIBODY PRESENT 1 0.0065
75 SKIN TEST POSITIVE 6 0.0064
76 ZYGOMYCOSIS 3 0.0064
77 GASTROENTERITIS ADENOVIRUS 1 0.0064
78 CHROMOSOMAL DELETION 1 0.0063
79 CAPILLARY LEAK SYNDROME 13 0.0063
80 RED BLOOD CELL SCHISTOCYTES PRESENT 2 0.0062
81 MEDIASTINAL HAEMATOMA 1 0.0060
82 CYSTITIS KLEBSIELLA 1 0.0060
83 RENAL TUBULAR INJURY 7 0.0058
84 BONE MARROW MYELOGRAM ABNORMAL 1 0.0057
85 ENCEPHALITIS VIRAL 7 0.0057
86 GRAFT VERSUS HOST DISEASE 41 0.0057
87 COMPLEMENT FACTOR DECREASED 1 0.0056
88 GRAFT LOSS 4 0.0055
89 BLOOD ZINC DECREASED 1 0.0055
90 EPSTEIN-BARR VIRAEMIA 6 0.0054
91 VIRAL MYOCARDITIS 2 0.0053
92 CYSTITIS VIRAL 2 0.0052
93 COMPUTERISED TOMOGRAM ABDOMEN ABNORMAL 1 0.0052
94 COOMBS NEGATIVE HAEMOLYTIC ANAEMIA 1 0.0051
95 EPSTEIN-BARR VIRUS ANTIBODY POSITIVE 2 0.0051
96 HYPERTENSIVE ENCEPHALOPATHY 3 0.0051
97 TRANSPLANT REJECTION 40 0.0050
98 APLASTIC ANAEMIA 26 0.0050
99 EPSTEIN-BARR VIRUS INFECTION 31 0.0050
100 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 7 0.0050
101 GASTROENTERITIS CRYPTOSPORIDIAL 1 0.0049
102 MUSCLE ABSCESS 3 0.0048
103 ADENOVIRAL HAEMORRHAGIC CYSTITIS 1 0.0048
104 HUMAN HERPESVIRUS 6 INFECTION 9 0.0048
105 APPARENT LIFE THREATENING EVENT 2 0.0047
106 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 13 0.0047
107 POLYSEROSITIS 2 0.0047
108 BLOOD STEM CELL TRANSPLANT FAILURE 1 0.0047
109 CYTOMEGALOVIRUS GASTROENTERITIS 1 0.0046
110 DISSEMINATED CYTOMEGALOVIRAL INFECTION 1 0.0046
111 LEFT VENTRICULAR END-DIASTOLIC PRESSURE INCREASED 1 0.0046
112 MILLER FISHER SYNDROME 1 0.0045
113 GRAFT VERSUS HOST DISEASE IN EYE 1 0.0043
114 MUCOSAL INFECTION 1 0.0043
115 ADENOVIRAL HEPATITIS 1 0.0043
116 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 9 0.0042
117 LYMPHOPROLIFERATIVE DISORDER 12 0.0041
118 CYTOMEGALOVIRUS VIRAEMIA 18 0.0040
119 MENINGORRHAGIA 1 0.0040
120 INTUBATION 1 0.0040
121 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 1 0.0040
122 FUNGAL PHARYNGITIS 1 0.0040
123 METASTASES TO THORAX 1 0.0040
124 LEUKAEMIC INFILTRATION EXTRAMEDULLARY 1 0.0039
125 GLOMERULONEPHROPATHY 1 0.0039
126 BONE MARROW RETICULIN FIBROSIS 1 0.0039
127 GRAFT THROMBOSIS 1 0.0038
128 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 5 0.0038
129 URTICARIAL VASCULITIS 2 0.0038
130 HYPOALDOSTERONISM 1 0.0036
131 CENTRAL NERVOUS SYSTEM NECROSIS 1 0.0036
132 GRAFT VERSUS HOST DISEASE IN SKIN 8 0.0036
133 ENTEROCOLITIS BACTERIAL 1 0.0036
134 CHRONIC GRAFT VERSUS HOST DISEASE 13 0.0036
135 CHEMICAL BURNS OF EYE 1 0.0036
136 GRAFT DYSFUNCTION 1 0.0035
137 T-CELL LYMPHOMA 4 0.0035
138 ROTAVIRUS INFECTION 2 0.0035
139 KIDNEY FIBROSIS 6 0.0035
140 HYPOURICAEMIA 1 0.0034
141 METAL POISONING 2 0.0034
142 SYSTEMIC MYCOSIS 4 0.0034
143 HEPATIC ARTERY THROMBOSIS 1 0.0034
144 GRAFT COMPLICATION 2 0.0034
145 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 1 0.0034
146 GINGIVAL HYPERPLASIA 2 0.0033
147 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 17 0.0033
148 ENTEROBACTER BACTERAEMIA 1 0.0033
149 GINGIVAL HYPERTROPHY 5 0.0033
150 BLOOD BETA-D-GLUCAN INCREASED 1 0.0033
151 OSTEOMYELITIS CHRONIC 2 0.0032
152 CONGENITAL APLASIA 1 0.0032
153 COOMBS DIRECT TEST POSITIVE 1 0.0032
154 EPSTEIN-BARR VIRUS TEST POSITIVE 2 0.0032
155 EYE INFECTION VIRAL 1 0.0031
156 ADENOVIRUS INFECTION 9 0.0031
157 BONE MARROW DEPRESSION 3 0.0031
158 BLOOD CREATINE PHOSPHOKINASE DECREASED 1 0.0030
159 HISTIOCYTOSIS HAEMATOPHAGIC 9 0.0030
160 INFUSION SITE REACTION 9 0.0030
161 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 7 0.0030
162 CYTOMEGALOVIRUS INFECTION REACTIVATION 13 0.0029
163 GIARDIASIS 1 0.0029
164 ORAL FUNGAL INFECTION 8 0.0029
165 TRANSPLANT FAILURE 7 0.0029
166 PSEUDOMONAL SEPSIS 5 0.0029
167 FUNGAL TEST POSITIVE 1 0.0028
168 VENOOCCLUSIVE LIVER DISEASE 14 0.0028
169 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 5 0.0028
170 COMPLICATIONS OF TRANSPLANTED LIVER 1 0.0028
171 PULMONARY SEPSIS 4 0.0027
172 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0027
173 MEDIASTINAL DISORDER 1 0.0027
174 BK VIRUS INFECTION 9 0.0027
175 STEROID DIABETES 4 0.0027
176 NON-CIRRHOTIC PORTAL HYPERTENSION 1 0.0027
177 CAPILLARY DISORDER 1 0.0026
178 AMYOTROPHY 1 0.0026
179 CRITICAL ILLNESS 2 0.0026
180 BREAKTHROUGH HAEMOLYSIS 1 0.0025
181 HEPATITIS VIRAL 2 0.0025
182 CAT SCRATCH DISEASE 1 0.0025
183 BLEEDING TIME PROLONGED 3 0.0025
184 HAPTOGLOBIN DECREASED 2 0.0025
185 SIMPLE PARTIAL SEIZURES 2 0.0025
186 LYMPHOCYTE PERCENTAGE INCREASED 1 0.0025
187 BACTERIAL SEPSIS 8 0.0025
188 SYSTEMIC INFECTION 4 0.0024
189 ACUTE GRAFT VERSUS HOST DISEASE 11 0.0024
190 STEM CELL TRANSPLANT 6 0.0024
191 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
192 BLOOD PRODUCT TRANSFUSION DEPENDENT 1 0.0024
193 PSEUDOMONAL BACTERAEMIA 2 0.0023
194 HYPERFERRITINAEMIA 1 0.0023
195 AUTOIMMUNE THROMBOCYTOPENIA 1 0.0023
196 OVARIAN CYST 23 0.0023
197 ASPERGILLOSIS 3 0.0023
198 ENCEPHALITIS CYTOMEGALOVIRUS 1 0.0023
199 OPERATIVE HAEMORRHAGE 1 0.0022
200 PARVOVIRUS B19 INFECTION 2 0.0022
201 MENINGOENCEPHALITIS HERPETIC 1 0.0022
202 HYPERPLASIA 2 0.0022
203 NEUROSIS 1 0.0022
204 URETERIC OBSTRUCTION 3 0.0022
205 MUCOSAL EROSION 2 0.0022
206 ANTI-THYROID ANTIBODY POSITIVE 1 0.0022
207 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 1 0.0022
208 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0022
209 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 14 0.0022
210 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 1 0.0021
211 BASEDOW'S DISEASE 1 0.0021
212 BONE MARROW TRANSPLANT 4 0.0021
213 LACRIMATION DECREASED 1 0.0021
214 GRAFT VERSUS HOST DISEASE IN LUNG 1 0.0021
215 EPSTEIN BARR VIRUS POSITIVE MUCOCUTANEOUS ULCER 1 0.0020
216 EVANS SYNDROME 1 0.0020
217 CELL DEATH 4 0.0020
218 VENOOCCLUSIVE DISEASE 5 0.0020
219 KAPOSI'S SARCOMA 1 0.0020
220 CSF TEST ABNORMAL 1 0.0020
221 CATHETER RELATED INFECTION 2 0.0020
222 PARAINFLUENZAE VIRUS INFECTION 3 0.0020
223 CYTOMEGALOVIRUS INFECTION 32 0.0019
224 FAECAL VOLUME INCREASED 1 0.0019
225 NEUTROPHIL PERCENTAGE DECREASED 1 0.0019
226 IRON OVERLOAD 2 0.0019
227 TOXOPLASMOSIS 2 0.0019
228 B-CELL LYMPHOMA RECURRENT 1 0.0018
229 PNEUMOCYSTIS JIROVECI PNEUMONIA 4 0.0018
230 LUNG CONSOLIDATION 5 0.0018
231 INTRAVASCULAR HAEMOLYSIS 1 0.0018
232 HAEMOGLOBINURIA 2 0.0018
233 LIFE SUPPORT 1 0.0018
234 INTRACRANIAL HAEMATOMA 1 0.0018
235 HEPATIC FIBROSIS 6 0.0017
236 APLASIA PURE RED CELL 6 0.0017
237 MEDIASTINITIS 1 0.0017
238 ACIDOSIS HYPERCHLORAEMIC 1 0.0017
239 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 2 0.0017
240 KIDNEY TRANSPLANT REJECTION 8 0.0017
241 MEAN PLATELET VOLUME INCREASED 1 0.0017
242 CEREBRAL VENOUS THROMBOSIS 3 0.0017
243 PNEUMONIA KLEBSIELLA 3 0.0016
244 BACILLUS INFECTION 1 0.0016
245 INTESTINAL FUNCTIONAL DISORDER 1 0.0016
246 BRAIN ABSCESS 4 0.0016
247 NOCARDIOSIS 4 0.0016
248 HEPATOSPLENOMEGALY 4 0.0016
249 THROMBOTIC MICROANGIOPATHY 15 0.0015
250 FASCIITIS 1 0.0015
251 PNEUMONIA FUNGAL 6 0.0015
252 CHRONIC MYELOMONOCYTIC LEUKAEMIA 1 0.0015
253 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 5 0.0015
254 STENOTROPHOMONAS INFECTION 2 0.0015
255 MARROW HYPERPLASIA 1 0.0015
256 CYTOKINE STORM 1 0.0015
257 FUSARIUM INFECTION 1 0.0014
258 HAEMORRHAGIC CEREBRAL INFARCTION 1 0.0014
259 DRUG TOLERANCE DECREASED 4 0.0014
260 STAPHYLOCOCCUS TEST POSITIVE 3 0.0014
261 BRONCHOPULMONARY ASPERGILLOSIS 11 0.0014
262 FEBRILE BONE MARROW APLASIA 6 0.0014
263 DELAYED GRAFT FUNCTION 1 0.0014
264 MENINGITIS BACTERIAL 2 0.0014
265 RENAL INFARCT 2 0.0014
266 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
267 GENERALISED OEDEMA 17 0.0014
268 ASPERGILLUS INFECTION 9 0.0014
269 SKIN MASS 9 0.0013
270 MYOCLONIC EPILEPSY 2 0.0013
271 CHEST X-RAY ABNORMAL 4 0.0013
272 PNEUMONIA PSEUDOMONAL 2 0.0013
273 DEBRIDEMENT 1 0.0013
274 EXTRADURAL ABSCESS 1 0.0013
275 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 1 0.0013
276 BLOOD FIBRINOGEN INCREASED 1 0.0013
277 ELECTROMECHANICAL DISSOCIATION 1 0.0013
278 ENTEROCOCCAL INFECTION 6 0.0012
279 CYSTITIS HAEMORRHAGIC 5 0.0012
280 ANAEMIA HAEMOLYTIC AUTOIMMUNE 1 0.0012
281 FUNGAL SEPSIS 1 0.0012
282 TROPONIN I INCREASED 2 0.0012
283 SYSTEMIC CANDIDA 3 0.0012
284 ENTEROBACTER INFECTION 2 0.0012
285 SPINAL DEFORMITY 2 0.0012
286 AMAUROSIS 1 0.0012
287 LEUKAEMIA RECURRENT 2 0.0012
288 APTYALISM 1 0.0012
289 COLONIC ABSCESS 1 0.0012
290 DIFFUSE LARGE B-CELL LYMPHOMA 9 0.0012
291 HEPATIC HAEMORRHAGE 1 0.0012
292 MUCORMYCOSIS 3 0.0012
293 HAEMOLYTIC ANAEMIA 10 0.0011
294 CANDIDA SEPSIS 1 0.0011
295 BLOOD MAGNESIUM INCREASED 1 0.0011
296 MULTI-ORGAN FAILURE 19 0.0011
297 BACTERAEMIA 13 0.0011
298 ANEURYSM RUPTURED 1 0.0011
299 EXTENSOR PLANTAR RESPONSE 1 0.0011
300 HAEMOCHROMATOSIS 1 0.0011
301 OPPORTUNISTIC INFECTION 2 0.0011
302 HYPERTRICHOSIS 2 0.0011
303 ADENOCARCINOMA OF COLON 2 0.0011
304 HYPOPROTEINAEMIA 2 0.0011
305 INTUSSUSCEPTION 1 0.0010
306 ESCHERICHIA SEPSIS 3 0.0010
307 LIVER FUNCTION TEST ABNORMAL 30 0.0010
308 STAPHYLOCOCCAL SEPSIS 5 0.0010
309 ENCEPHALITIS 7 0.0010
310 BLOOD LACTATE DEHYDROGENASE INCREASED 16 0.0010
311 CEREBRAL ATROPHY 4 0.0010
312 CANDIDIASIS 4 0.0010
313 LYMPHOCYTIC INFILTRATION 1 0.0010
314 RENAL HAEMORRHAGE 2 0.0010
315 BRAIN STEM INFARCTION 1 0.0010
316 HEART TRANSPLANT REJECTION 1 0.0010
317 SKIN NECROSIS 5 0.0010
318 ENTEROCOCCAL BACTERAEMIA 1 0.0009
319 PSEUDOMONAS INFECTION 8 0.0009
320 FACIAL PALSY 2 0.0009
321 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
322 HAEMORRHAGIC DISORDER 1 0.0009
323 SEPTIC SHOCK 40 0.0009
324 KIDNEY ENLARGEMENT 1 0.0009
325 HEPATOCELLULAR INJURY 13 0.0009
326 NOSOCOMIAL INFECTION 2 0.0009
327 CLOSTRIDIUM TEST POSITIVE 2 0.0009
328 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 1 0.0009
329 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
330 KLEBSIELLA SEPSIS 1 0.0009
331 CEREBRAL VENTRICLE DILATATION 1 0.0009
332 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
333 DILATATION ATRIAL 1 0.0009
334 BLOOD BILIRUBIN INCREASED 23 0.0009
335 ESCHERICHIA BACTERAEMIA 2 0.0008
336 MYOPIA 2 0.0008
337 DYSPLASIA 1 0.0008
338 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
339 MONOCYTE COUNT DECREASED 1 0.0008
340 GLOMERULONEPHRITIS 2 0.0008
341 HAEMATOCRIT ABNORMAL 1 0.0008
342 BENIGN INTRACRANIAL HYPERTENSION 1 0.0008
343 TOXIC SKIN ERUPTION 8 0.0008
344 HYPERTHERMIA 6 0.0008
345 HEPATIC CYTOLYSIS 10 0.0008
346 HYPOALBUMINAEMIA 6 0.0008
347 HERPES SIMPLEX 5 0.0008
348 HEPATITIS TOXIC 2 0.0008
349 NON-HODGKIN'S LYMPHOMA 1 0.0008
350 TRANSAMINASES INCREASED 17 0.0008
351 RASH MACULO-PAPULAR 17 0.0008
352 OBLITERATIVE BRONCHIOLITIS 1 0.0008
353 LUNG OPACITY 2 0.0008
354 HIRSUTISM 1 0.0008
355 GLYCOSURIA 1 0.0007
356 MUCOUS MEMBRANE DISORDER 1 0.0007
357 INFUSION SITE RASH 1 0.0007
358 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0007
359 H1N1 INFLUENZA 1 0.0007
360 MYELITIS TRANSVERSE 1 0.0007
361 ALVEOLITIS 1 0.0007
362 NEUTROPENIC SEPSIS 5 0.0007
363 CEREBELLAR HAEMORRHAGE 1 0.0007
364 NEUROLOGICAL SYMPTOM 4 0.0007
365 INVESTIGATION ABNORMAL 1 0.0007
366 BONE MARROW FAILURE 14 0.0007
367 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 1 0.0007
368 GASTROINTESTINAL NECROSIS 2 0.0007
369 LUNG INFILTRATION 6 0.0007
370 BLOOD PARATHYROID HORMONE DECREASED 1 0.0007
371 NEPHRECTOMY 1 0.0007
372 BLOOD CULTURE POSITIVE 2 0.0007
373 NEPHROGENIC SYSTEMIC FIBROSIS 2 0.0007
374 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
375 BLOOD PRESSURE IMMEASURABLE 1 0.0007
376 FIBROSIS 2 0.0006
377 MUCOSAL INFLAMMATION 17 0.0006
378 NEURITIS 1 0.0006
379 HAEMOLYSIS 5 0.0006
380 MYELITIS 1 0.0006
381 THERAPY PARTIAL RESPONDER 10 0.0006
382 PULMONARY HAEMORRHAGE 5 0.0006
383 BLOOD CREATININE DECREASED 2 0.0006
384 HEPATITIS E 1 0.0006
385 IDIOPATHIC THROMBOCYTOPENIC PURPURA 1 0.0006
386 HEPATITIS B REACTIVATION 2 0.0006
387 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 6 0.0006
388 JC VIRUS INFECTION 1 0.0006
389 CHOLESTASIS 12 0.0006
390 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1 0.0006
391 INTRA-UTERINE DEATH 1 0.0006
392 LIVER ABSCESS 2 0.0006
393 LYMPHOCYTE COUNT INCREASED 2 0.0006
394 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
395 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 2 0.0006
396 ANTIBODY TEST POSITIVE 1 0.0006
397 CYTOLYTIC HEPATITIS 2 0.0006
398 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
399 KLEBSIELLA INFECTION 3 0.0006
400 WOUND DEHISCENCE 2 0.0006
401 TACHYPNOEA 8 0.0006
402 BLOOD AMYLASE INCREASED 1 0.0006
403 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
404 INFUSION SITE DISCHARGE 1 0.0006
405 BRONCHIOLITIS 2 0.0006
406 NECROTISING FASCIITIS 2 0.0006
407 PURPURA 5 0.0006
408 CYTOMEGALOVIRUS TEST POSITIVE 1 0.0006
409 BEHAVIOUR DISORDER 3 0.0006
410 LIVER TRANSPLANT 2 0.0005
411 CONDUCTION DISORDER 1 0.0005
412 INTESTINAL ISCHAEMIA 3 0.0005
413 INJECTION SITE CELLULITIS 1 0.0005
414 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
415 MECHANICAL VENTILATION 1 0.0005
416 HAEMODYNAMIC INSTABILITY 4 0.0005
417 MENOMETRORRHAGIA 1 0.0005
418 HYPOREFLEXIA 1 0.0005
419 ARTERIAL THROMBOSIS 1 0.0005
420 VIRAL LOAD INCREASED 2 0.0005
421 ATROPHY 1 0.0005
422 CYTOMEGALOVIRUS CHORIORETINITIS 1 0.0005
423 ARTERIOSPASM CORONARY 2 0.0005
424 RHINITIS 4 0.0005
425 EYELID PAIN 1 0.0005
426 ARTHRITIS BACTERIAL 2 0.0005
427 EXTRAVASATION 2 0.0005
428 HYPERURICAEMIA 2 0.0005
429 MYELODYSPLASTIC SYNDROME 7 0.0005
430 INSULIN RESISTANCE 1 0.0005
431 LIVEDO RETICULARIS 1 0.0005
432 PULSELESS ELECTRICAL ACTIVITY 2 0.0005
433 LUNG ABSCESS 1 0.0005
434 DILATATION VENTRICULAR 1 0.0005
435 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
436 HYPERKINESIA 1 0.0005
437 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
438 NEUTROPHIL COUNT DECREASED 19 0.0005
439 PLATELET COUNT DECREASED 49 0.0005
440 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
441 INFUSION RELATED REACTION 30 0.0005
442 PANCYTOPENIA 25 0.0004
443 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
444 COMPLICATIONS OF TRANSPLANTED KIDNEY 1 0.0004
445 PNEUMONIA ASPIRATION 11 0.0004
446 END STAGE RENAL DISEASE 8 0.0004
447 CYTOMEGALOVIRUS COLITIS 1 0.0004
448 NEUROLOGICAL DECOMPENSATION 1 0.0004
449 BILIRUBIN CONJUGATED INCREASED 1 0.0004
450 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
451 PULSE ABSENT 2 0.0004
452 EOSINOPHIL COUNT DECREASED 1 0.0004
453 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
454 HAEMOGLOBIN DECREASED 43 0.0004
455 SINUS BRADYCARDIA 4 0.0004
456 SEPSIS 46 0.0004
457 METRORRHAGIA 7 0.0004
458 NO THERAPEUTIC RESPONSE 5 0.0004
459 DERMAL CYST 1 0.0004
460 HEPATOMEGALY 4 0.0004
461 ABDOMINAL TENDERNESS 2 0.0004
462 HAEMORRHAGE INTRACRANIAL 6 0.0004
463 PROTEIN URINE PRESENT 2 0.0004
464 HYDRONEPHROSIS 3 0.0004
465 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
466 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
467 TOXIC ENCEPHALOPATHY 2 0.0004
468 ACIDOSIS 3 0.0004
469 DISSEMINATED TUBERCULOSIS 1 0.0004
470 MEAN CELL VOLUME INCREASED 1 0.0004
471 HYPERBILIRUBINAEMIA 4 0.0004
472 ACUTE KIDNEY INJURY 59 0.0004
473 PETECHIAE 4 0.0004
474 FOLLICULITIS 4 0.0004
475 SERUM FERRITIN INCREASED 2 0.0004
476 FEBRILE NEUTROPENIA 25 0.0004
477 AREFLEXIA 1 0.0004
478 TREATMENT FAILURE 31 0.0004
479 GINGIVITIS 2 0.0004
480 LARGE INTESTINAL ULCER 1 0.0004
481 HYPERAESTHESIA 3 0.0004
482 ESCHERICHIA INFECTION 3 0.0004
483 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
484 EMBOLISM 3 0.0004
485 STREPTOCOCCAL INFECTION 2 0.0004
486 HAEMODIALYSIS 3 0.0004
487 ANAL HAEMORRHAGE 1 0.0004
488 MENORRHAGIA 7 0.0004
489 THERAPY NON-RESPONDER 16 0.0004
490 NEUTROPHIL COUNT ABNORMAL 1 0.0004
491 IMMUNE THROMBOCYTOPENIC PURPURA 1 0.0004
492 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10 0.0004
493 HAEMATOCRIT DECREASED 7 0.0004
494 HEPATITIS 9 0.0004
495 OESOPHAGEAL STENOSIS 1 0.0004
496 MYOCARDIAL ISCHAEMIA 4 0.0004
497 SUBDURAL HAEMATOMA 5 0.0003
498 LUNG CANCER METASTATIC 1 0.0003
499 ENTEROCOLITIS 2 0.0003
500 ELECTROLYTE IMBALANCE 4 0.0003
501 PYREXIA 118 0.0003
502 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
503 PLEURISY 2 0.0003
504 CEREBRAL HAEMORRHAGE 12 0.0003
505 BRAIN HERNIATION 1 0.0003
506 METABOLIC ENCEPHALOPATHY 1 0.0003
507 CEREBROVASCULAR DISORDER 1 0.0003
508 OSTEOMYELITIS 6 0.0003
509 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
510 ACNE 25 0.0003
511 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
512 RESPIRATORY DISTRESS 9 0.0003
513 DUODENITIS 1 0.0003
514 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
515 BRAIN DEATH 1 0.0003
516 OLIGURIA 2 0.0003
517 DIARRHOEA HAEMORRHAGIC 3 0.0003
518 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
519 ORTHOPNOEA 1 0.0003
520 HYPOXIA 11 0.0003
521 CUSHINGOID 1 0.0003
522 PROCTALGIA 2 0.0003
523 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0003
524 DRUG SPECIFIC ANTIBODY PRESENT 2 0.0003
525 HYPOVENTILATION 1 0.0003
526 RENAL FAILURE ACUTE 13 0.0003
527 RENAL TUBULAR NECROSIS 3 0.0003
528 HYPOGAMMAGLOBULINAEMIA 2 0.0003
529 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
530 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
531 CARDIAC FAILURE ACUTE 2 0.0003
532 NEPHRITIS 1 0.0003
533 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
534 HYPOTHERMIA 3 0.0003
535 CLOSTRIDIAL INFECTION 1 0.0003
536 NEOPLASM RECURRENCE 1 0.0003
537 SUBARACHNOID HAEMORRHAGE 3 0.0003
538 EPILEPSY 9 0.0003
539 DRUG TOXICITY 4 0.0003
540 CIRCULATORY COLLAPSE 5 0.0003
541 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
542 BLOOD CREATININE INCREASED 19 0.0003
543 LEFT VENTRICULAR FAILURE 1 0.0003
544 GRANULOMA 1 0.0003
545 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
546 DUODENAL ULCER 2 0.0003
547 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
548 PULMONARY TOXICITY 2 0.0003
549 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
550 GLOSSITIS 1 0.0003
551 FIBRIN D DIMER INCREASED 1 0.0003
552 LEUKOPENIA 14 0.0003
553 VISUAL FIELD DEFECT 2 0.0003
554 FLUID OVERLOAD 4 0.0003
555 C-REACTIVE PROTEIN INCREASED 10 0.0003
556 OESOPHAGITIS 3 0.0003
557 CUTANEOUS VASCULITIS 1 0.0003
558 COMA 13 0.0003
559 LEUKOENCEPHALOPATHY 1 0.0003
560 HEPATIC NECROSIS 1 0.0003
561 MITRAL VALVE INCOMPETENCE 3 0.0003
562 GINGIVAL DISORDER 1 0.0003
563 PRODUCT USE IN UNAPPROVED INDICATION 64 0.0003
564 ACUTE MYELOID LEUKAEMIA 4 0.0003
565 GOITRE 1 0.0002
566 DEMYELINATION 1 0.0002
567 FUNGAL INFECTION 8 0.0002
568 CONGESTIVE CARDIOMYOPATHY 1 0.0002
569 BRAIN OEDEMA 3 0.0002
570 HYPERTENSION 50 0.0002
571 RENAL INJURY 7 0.0002
572 ABSCESS LIMB 1 0.0002
573 LUNG NEOPLASM 1 0.0002
574 ANURIA 2 0.0002
575 WHITE BLOOD CELL COUNT DECREASED 25 0.0002
576 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
577 URINE OUTPUT DECREASED 2 0.0002
578 NEUROTOXICITY 4 0.0002
579 LYMPHOCYTE COUNT DECREASED 4 0.0002
580 DYSMENORRHOEA 3 0.0002
581 RENAL FAILURE 30 0.0002
582 BLOOD CREATINE INCREASED 1 0.0002
583 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
584 EYE HAEMORRHAGE 3 0.0002
585 HEPATOTOXICITY 5 0.0002
586 CARDIOTOXICITY 2 0.0002
587 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
588 GINGIVAL BLEEDING 3 0.0002
589 HYPERGLYCAEMIA 8 0.0002
590 HAEMOGLOBIN INCREASED 1 0.0002
591 IMMUNE THROMBOCYTOPENIA 1 0.0002
592 PNEUMONIA BACTERIAL 2 0.0002
593 LOCALISED OEDEMA 1 0.0002
594 HAEMOPTYSIS 6 0.0002
595 ERYTHEMA MULTIFORME 2 0.0002
596 BACTERIAL INFECTION 4 0.0002
597 CHILLS 25 0.0002
598 STAPHYLOCOCCAL INFECTION 7 0.0002
599 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
600 DIALYSIS 3 0.0002
601 ACUTE RESPIRATORY FAILURE 4 0.0002
602 GUILLAIN-BARRE SYNDROME 1 0.0002
603 CEREBRAL INFARCTION 5 0.0002
604 ASCITES 6 0.0002
605 LUNG DISORDER 10 0.0002
606 RENAL IMPAIRMENT 17 0.0002
607 MUCOUS STOOLS 1 0.0002
608 COLON CANCER 3 0.0002
609 ANEURYSM 1 0.0002
610 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
611 ERYSIPELAS 1 0.0002
612 DYSLIPIDAEMIA 1 0.0002
613 NEUTROPHIL COUNT INCREASED 2 0.0002
614 DEVICE RELATED INFECTION 3 0.0002
615 CACHEXIA 1 0.0002
616 INFLAMMATION 10 0.0002
617 RENAL DISORDER 9 0.0002
618 LUNG INFECTION 3 0.0002
619 FAILURE TO THRIVE 1 0.0002
620 BASAL CELL CARCINOMA 3 0.0002
621 BLOOD LACTIC ACID INCREASED 1 0.0002
622 RENAL PAIN 2 0.0002
623 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
624 INTESTINAL RESECTION 1 0.0002
625 ANAL ABSCESS 1 0.0002
626 HYDROCEPHALUS 1 0.0002
627 WOUND INFECTION 2 0.0002
628 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 10 0.0002
629 MELAENA 4 0.0002
630 CARDIAC ARREST 15 0.0002
631 HYPERKERATOSIS 1 0.0002
632 DRUG LEVEL INCREASED 3 0.0002
633 LIVER DISORDER 8 0.0002
634 COAGULOPATHY 3 0.0002
635 HYPERTENSIVE CRISIS 2 0.0002
636 HEART RATE ABNORMAL 1 0.0002
637 BLOOD UREA INCREASED 3 0.0002
638 RESPIRATORY FAILURE 13 0.0002
639 ACUTE PULMONARY OEDEMA 1 0.0002
640 HEPATIC ENZYME INCREASED 12 0.0002
641 GENERALISED ERYTHEMA 1 0.0002
642 HERPES VIRUS INFECTION 1 0.0002
643 PERICARDIAL EFFUSION 4 0.0002
644 HYPERVENTILATION 1 0.0002
645 VASCULITIS 2 0.0002
646 LYMPHADENOPATHY 6 0.0002
647 DISEASE PROGRESSION 20 0.0002
648 ODYNOPHAGIA 1 0.0002
649 RASH ERYTHEMATOUS 8 0.0002
650 URTICARIA 28 0.0002
651 HEPATITIS B 1 0.0002
652 DERMATITIS ACNEIFORM 1 0.0002
653 PLEURAL EFFUSION 10 0.0002
654 CHOLANGITIS 1 0.0002
655 THROMBOCYTOPENIA 18 0.0002
656 NERVOUS SYSTEM DISORDER 5 0.0002
657 HAEMATEMESIS 4 0.0002
658 PULMONARY OEDEMA 7 0.0002
659 ENTERITIS 1 0.0002
660 POST PROCEDURAL COMPLICATION 3 0.0002
661 MYDRIASIS 2 0.0002
662 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
663 PLATELET COUNT INCREASED 2 0.0002
664 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
665 VIRAL INFECTION 5 0.0002
666 MENINGITIS 1 0.0001
667 GASTROOESOPHAGEAL REFLUX DISEASE 12 0.0001
668 JAUNDICE 4 0.0001
669 STOMATITIS 9 0.0001
670 COLITIS ISCHAEMIC 1 0.0001
671 TASTE DISORDER 3 0.0001
672 DISEASE RECURRENCE 7 0.0001
673 PNEUMONITIS 4 0.0001
674 EYE MOVEMENT DISORDER 1 0.0001
675 NEPHROTIC SYNDROME 1 0.0001
676 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
677 PERITONITIS 3 0.0001
678 DIABETES MELLITUS 11 0.0001
679 MENTAL STATUS CHANGES 4 0.0001
680 AUTOIMMUNE HEPATITIS 1 0.0001
681 HYPERTRANSAMINASAEMIA 1 0.0001
682 HYPOMAGNESAEMIA 2 0.0001
683 LYMPHOPENIA 2 0.0001
684 SINUS TACHYCARDIA 2 0.0001
685 BRONCHOSPASM 2 0.0001
686 RED BLOOD CELL COUNT DECREASED 4 0.0001
687 CONVULSION 8 0.0001
688 CARDIOGENIC SHOCK 2 0.0001
689 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
690 INFECTION 20 0.0001
691 TOXICITY TO VARIOUS AGENTS 23 0.0001
692 HYPOPHOSPHATAEMIA 1 0.0001
693 CEREBRAL DISORDER 1 0.0001
694 ORAL PAIN 3 0.0001
695 RESPIRATORY DISORDER 4 0.0001
696 ATRIAL FIBRILLATION 13 0.0001
697 HEPATIC FAILURE 4 0.0001
698 BRADYCARDIA 7 0.0001
699 THERAPEUTIC RESPONSE DECREASED 8 0.0001
700 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
701 BOWEL MOVEMENT IRREGULARITY 1 0.0001
702 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
703 BLOOD ALBUMIN DECREASED 1 0.0001
704 GINGIVAL PAIN 1 0.0001
705 ATRIAL FLUTTER 1 0.0001
706 CARDIAC FAILURE 10 0.0001
707 TACHYCARDIA 11 0.0001
708 PRODUCT USE ISSUE 23 0.0001
709 LIVER INJURY 3 0.0001
710 ALOPECIA 24 0.0001
711 MENSTRUAL DISORDER 1 0.0001
712 ACUTE CORONARY SYNDROME 1 0.0001
713 HEMIPLEGIA 1 0.0001
714 CANDIDA INFECTION 2 0.0001
715 HAEMATURIA 4 0.0001
716 DRUG RESISTANCE 3 0.0001
717 ANAPHYLACTIC SHOCK 3 0.0001
718 VAGINAL HAEMORRHAGE 5 0.0001
719 RHEUMATOID ARTHRITIS 13 0.0001
720 HYPERKALAEMIA 4 0.0001
721 GROIN PAIN 1 0.0001
722 IMMUNOSUPPRESSION 1 0.0001
723 CARDIAC FAILURE CONGESTIVE 9 0.0001
724 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
725 HYPOTENSION 22 0.0001
726 UNDERDOSE 8 0.0001
727 SKIN LESION 3 0.0001
728 ANAPHYLACTIC REACTION 6 0.0001
729 GRAND MAL CONVULSION 1 0.0001
730 AGRANULOCYTOSIS 2 0.0001
731 HEPATIC FUNCTION ABNORMAL 4 0.0001
732 APPENDICITIS 1 0.0001
733 HYPONATRAEMIA 6 0.0001
734 PHOTOPHOBIA 2 0.0001
735 HYPOCALCAEMIA 2 0.0001
736 PROTEINURIA 2 0.0001
737 ATELECTASIS 1 0.0001
738 DYSSTASIA 3 0.0001
739 AUTOIMMUNE DISORDER 1 0.0001
740 ORAL HERPES 2 0.0001
741 PREGNANCY 2 0.0001
742 CYTOKINE RELEASE SYNDROME 2 0.0001
743 FULL BLOOD COUNT DECREASED 2 0.0001
744 MOTOR DYSFUNCTION 1 0.0001
745 PNEUMONIA 31 0.0001
746 CARDIO-RESPIRATORY ARREST 4 0.0001
747 AGITATION 7 0.0001
748 RASH PRURITIC 5 0.0001
749 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
750 BLOOD GLUCOSE FLUCTUATION 1 0.0001
751 GASTROINTESTINAL PAIN 1 0.0001
752 DENTAL CARIES 1 0.0001
753 VISUAL ACUITY REDUCED 3 0.0001
754 STEVENS-JOHNSON SYNDROME 2 0.0001
755 NEPHROPATHY TOXIC 1 0.0001
756 PANCREATITIS ACUTE 2 0.0001
757 BLOOD CALCIUM DECREASED 1 0.0001
758 NEUTROPENIA 12 0.0001
759 INTERNAL HAEMORRHAGE 1 0.0001
760 MYOCARDITIS 1 0.0001
761 THROMBOSIS 7 0.0001
762 GASTRIC HAEMORRHAGE 1 0.0001
763 GENERAL PHYSICAL HEALTH DETERIORATION 10 0.0001
764 EYELID OEDEMA 1 0.0001
765 CAESAREAN SECTION 1 0.0001
766 BONE PAIN 5 0.0001
767 COVID-19 PNEUMONIA 1 0.0001
768 CHOLECYSTITIS 1 0.0001
769 DIABETIC KETOACIDOSIS 2 0.0001
770 ABDOMINAL PAIN UPPER 17 0.0001
771 ADRENAL INSUFFICIENCY 1 0.0001
772 URINARY TRACT INFECTION 14 0.0001
773 CYTOPENIA 1 0.0001
774 ENCEPHALOPATHY 2 0.0001
775 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
776 CARDIOMEGALY 1 0.0001
777 CYST 1 0.0001
778 ILEUS 1 0.0001
779 HALLUCINATION 6 0.0001
780 ANAEMIA 15 0.0001
781 GASTROINTESTINAL DISORDER 7 0.0001
782 THERAPY CESSATION 4 0.0001
783 GENITAL HAEMORRHAGE 1 0.0001
784 ANOREXIA 1 0.0001
785 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
786 DEEP VEIN THROMBOSIS 5 0.0001
787 RESPIRATORY TRACT INFECTION 2 0.0001
788 MYALGIA 13 0.0001
789 DISORIENTATION 3 0.0001
790 NEOPLASM MALIGNANT 5 0.0001
791 SOMNOLENCE 15 0.0001
792 OEDEMA 4 0.0001
793 PULMONARY EMBOLISM 7 0.0001
794 RASH 32 0.0001
795 ACUTE HEPATIC FAILURE 1 0.0001
796 RESPIRATORY ARREST 2 0.0001
797 DIVERTICULITIS 2 0.0001
798 FEELING COLD 2 0.0001
799 INFLUENZA 8 0.0001
800 COORDINATION ABNORMAL 1 0.0001
801 MASS 1 0.0001
802 BLOOD TEST ABNORMAL 1 0.0001
803 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
804 RECTAL HAEMORRHAGE 3 0.0001
805 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
806 HYPERTHYROIDISM 1 0.0001
807 GASTROENTERITIS 1 0.0001
808 CONFUSIONAL STATE 11 0.0001
809 ANGIOEDEMA 3 0.0001
810 CARDIOMYOPATHY 1 0.0001
811 THROAT IRRITATION 3 0.0001
812 EPISTAXIS 5 0.0001
813 CONDITION AGGRAVATED 20 0.0001
814 OEDEMA PERIPHERAL 8 0.0001
815 HYPOKALAEMIA 3 0.0001
816 OVERDOSE 14 0.0001
817 LYMPHOMA 1 0.0001
818 ANKLE FRACTURE 1 0.0001
819 EJECTION FRACTION DECREASED 1 0.0001
820 CYANOSIS 1 0.0001
821 HYPOTHYROIDISM 2 0.0001
822 LOSS OF CONSCIOUSNESS 8 0.0001
823 CONTUSION 6 0.0001
824 NIGHT SWEATS 2 0.0001
825 OSTEONECROSIS 2 0.0001
826 EYE DISORDER 2 0.0001
827 HEART RATE INCREASED 6 0.0001
828 DRUG INEFFECTIVE 79 0.0001
829 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
830 CELLULITIS 3 0.0001
831 CHEST PAIN 11 0.0001
832 OFF LABEL USE 52 0.0001
833 FACE OEDEMA 1 0.0001
834 RASH MACULAR 2 0.0001
835 AMENORRHOEA 1 0.0001
836 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
837 ISCHAEMIC STROKE 1 0.0001
838 GALLBLADDER DISORDER 1 0.0001
839 LEUKOCYTOSIS 1 0.0001
840 TREATMENT NONCOMPLIANCE 3 0.0001
841 DYSURIA 2 0.0001
842 CONJUNCTIVITIS 1 0.0001
843 NECK PAIN 3 0.0001
844 OXYGEN SATURATION DECREASED 3 0.0001
845 INTESTINAL OBSTRUCTION 2 0.0001
846 BLOOD SODIUM DECREASED 1 0.0001
847 BLOOD URINE PRESENT 1 0.0001
848 HEADACHE 33 0.0001
849 HAEMORRHOIDS 1 0.0001
850 PLASMA CELL MYELOMA 2 0.0001
851 BLOOD PRESSURE ABNORMAL 1 0.0001
852 IRRITABILITY 3 0.0000
853 DYSKINESIA 2 0.0000
854 BODY TEMPERATURE INCREASED 1 0.0000
855 ERYTHEMA 10 0.0000
856 VISUAL IMPAIRMENT 6 0.0000
857 DERMATITIS 1 0.0000
858 ABDOMINAL PAIN 11 0.0000
859 LIVER FUNCTION TEST INCREASED 1 0.0000
860 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
861 BLOOD PRESSURE DECREASED 3 0.0000
862 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
863 VOMITING 21 0.0000
864 CHROMATURIA 1 0.0000
865 SEIZURE 5 0.0000
866 DRUG INTOLERANCE 4 0.0000
867 LOCALISED INFECTION 1 0.0000
868 NEURALGIA 1 0.0000
869 INJECTION SITE URTICARIA 1 0.0000
870 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
871 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
872 BLOOD PRESSURE INCREASED 6 0.0000
873 DYSPNOEA 22 0.0000
874 DIARRHOEA 25 0.0000
875 HAEMATOMA 1 0.0000
876 DIPLOPIA 1 0.0000
877 HAEMORRHAGE 4 0.0000
878 DEAFNESS 1 0.0000
879 GASTRITIS 1 0.0000
880 PANCREATITIS 2 0.0000
881 DRUG INTERACTION 6 0.0000
882 EAR INFECTION 1 0.0000
883 PAIN 23 0.0000
884 MOOD ALTERED 1 0.0000
885 HAEMATOCHEZIA 2 0.0000
886 ANGINA PECTORIS 1 0.0000
887 LABORATORY TEST ABNORMAL 1 0.0000
888 CATARACT 2 0.0000
889 APHASIA 1 0.0000
890 DRUG ADMINISTRATION ERROR 1 0.0000
891 HOSPITALISATION 5 0.0000
892 HYPERSENSITIVITY 6 0.0000
893 LIMB DISCOMFORT 1 0.0000
894 WEIGHT DECREASED 9 0.0000
895 EXPOSURE DURING PREGNANCY 2 0.0000
896 COUGH 9 0.0000
897 NEUROPATHY PERIPHERAL 3 0.0000
898 CYSTITIS 1 0.0000
899 METABOLIC ACIDOSIS 1 0.0000
900 RHINORRHOEA 2 0.0000
901 LACTIC ACIDOSIS 1 0.0000
902 SWELLING FACE 2 0.0000
903 IMPAIRED HEALING 1 0.0000
904 LIP SWELLING 1 0.0000
905 GAIT INABILITY 1 0.0000
906 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
907 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
908 ASTHENIA 11 0.0000
909 VISION BLURRED 4 0.0000
910 ARTHRALGIA 12 0.0000
911 DELIRIUM 1 0.0000
912 COVID-19 5 0.0000
913 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
914 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
915 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
916 MYELOSUPPRESSION 1 0.0000
917 NO ADVERSE EVENT 5 0.0000
918 DYSARTHRIA 1 0.0000
919 COLITIS 1 0.0000
920 CHRONIC KIDNEY DISEASE 2 0.0000
921 GAIT DISTURBANCE 5 0.0000
922 DECREASED APPETITE 6 0.0000
923 BACK PAIN 6 0.0000
924 PALPITATIONS 3 0.0000
925 NAUSEA 20 0.0000
926 ABNORMAL BEHAVIOUR 1 0.0000
927 ABORTION SPONTANEOUS 1 0.0000
928 BLINDNESS 1 0.0000
929 TREMOR 4 0.0000
930 HYPOACUSIS 1 0.0000
931 DEATH 20 0.0000
932 BALANCE DISORDER 2 0.0000
933 COLITIS ULCERATIVE 1 0.0000
934 ADVERSE DRUG REACTION 2 0.0000
935 NEPHROLITHIASIS 1 0.0000
936 OROPHARYNGEAL PAIN 2 0.0000
937 BLOOD CHOLESTEROL INCREASED 1 0.0000
938 COGNITIVE DISORDER 1 0.0000
939 SWELLING 2 0.0000
940 DYSPHAGIA 2 0.0000
941 MULTIPLE SCLEROSIS 1 0.0000
942 BLOOD GLUCOSE DECREASED 1 0.0000
943 INTERSTITIAL LUNG DISEASE 1 0.0000
944 HYPOGLYCAEMIA 1 0.0000
945 PAIN IN EXTREMITY 6 0.0000
946 AGGRESSION 1 0.0000
947 CHEST DISCOMFORT 2 0.0000
948 SINUSITIS 2 0.0000
949 PERIPHERAL SWELLING 3 0.0000
950 ILLNESS 2 0.0000
951 MUSCULOSKELETAL PAIN 1 0.0000
952 DRUG EFFECT DECREASED 1 0.0000
953 MEDICATION ERROR 1 0.0000
954 BLISTER 1 0.0000
955 EYE PAIN 1 0.0000
956 INCORRECT DOSE ADMINISTERED 4 0.0000
957 HERPES ZOSTER 1 0.0000
958 MYOCARDIAL INFARCTION 3 0.0000
959 NASAL CONGESTION 1 0.0000
960 DISCOMFORT 1 0.0000
961 MUSCLE SPASMS 3 0.0000
962 FEELING HOT 1 0.0000
963 BLOOD GLUCOSE INCREASED 3 0.0000
964 PRURITUS 6 0.0000
965 DEHYDRATION 2 0.0000
966 INJECTION SITE PRURITUS 1 0.0000
967 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
968 MEMORY IMPAIRMENT 2 0.0000
969 FATIGUE 11 0.0000
970 MALAISE 6 0.0000
971 BRONCHITIS 1 0.0000
972 WEIGHT INCREASED 3 0.0000
973 PARAESTHESIA 2 0.0000
974 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
975 ABDOMINAL DISCOMFORT 2 0.0000
976 INSOMNIA 3 0.0000
977 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
978 ADVERSE EVENT 1 0.0000
979 NASOPHARYNGITIS 2 0.0000
980 ANXIETY 3 0.0000
981 MIGRAINE 1 0.0000
982 FLUSHING 1 0.0000
983 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
984 ABDOMINAL DISTENSION 1 0.0000
985 MUSCULAR WEAKNESS 1 0.0000
986 DEPRESSION 2 0.0000
987 FEELING ABNORMAL 2 0.0000
988 HYPOAESTHESIA 1 0.0000
989 CONSTIPATION 1 0.0000
990 DIZZINESS 1 0.0000